Biological Age Tests

Biological Age vs. Chronological Age

Chronological age counts years since birth. Biological age estimates wear and tear from biomarkers. The gap predicts risk in groups, not fate in individuals.

10 min read · Longevity365 Editorial

You know your chronological age. It’s on your driver’s license, it goes up by one every birthday, and nobody has ever tried to sell you a kit to measure it. What a test kit, a clinic or a headline may have just told you is that you also have a biological age, and that it can be a different number. Humanic Blue is here to untangle what those two numbers do—and don’t—tell you.

Chronological age counts time since birth. Biological age is a model’s estimate from measurements such as blood markers or DNA methylation, the chemical tags on DNA that some clocks read. Different models answer different questions, and a younger-looking result does not establish that you will live longer. Biological age vs chronological age is a comparison between a calendar fact and an estimate—not two equally certain measurements.

Researchers have linked older-than-expected scores on several clocks to illness and earlier death in large groups. Those associations do not give one person a precise forecast or show that lowering a score helps people live longer and better. The method, its measurement error and what it was trained to predict all matter.

Key Takeaways

  • Chronological age is elapsed time; biological age is an estimate from a model. Established.
  • Different clocks measure different features and can disagree. Supported.
  • Several clocks predict illness or mortality in groups, but a result is not an individual diagnosis. Supported.
  • Repeat measurements can vary even when the underlying sample has not changed. Supported.
  • A younger clock reading is not proof of a longer life. Unknown as a treatment outcome.

What does “biological age” actually mean, in one blunt sentence?

Biological age is a number calculated from measurements of your body using a model developed from other people’s data.

There’s no organ in your body that stores it. Every version of it is a model, and different models measure different things: DNA methylation (chemical tags on your DNA that shift predictably with age), proteins in the liquid part of blood, routine blood-test values, or a mix.

Because each model is trained on a different dataset with a different goal, they don’t agree with each other. That’s the first thing worth knowing before you take any one number personally.

Steve Horvath developed the 2013 Horvath clock at UCLA and subsequently worked at Altos Labs. Speaking to The Scientist, he put the state of the field plainly: “There’s no question that epigenetic clocks perform very well in epidemiological studies. But what the field has not yet achieved is really what one would call reference standards.” Translation: the clocks work on populations; nobody has agreed what a “correct” reading for one person would look like.

If chronological age is so crude, why do doctors still use it?

Because it remains the single strongest predictor of most chronic diseases.

The National Institute on Aging’s geroscience program describes aging as a major risk factor for multiple chronic diseases, frailty and reduced resilience. That does not mean a birthday predicts an individual’s future precisely.

Researchers use chronological age as a point of comparison when testing whether a biological-age model adds useful information. Morgan Levine, PhD, who developed PhenoAge and later ran labs at Yale and at Altos Labs, designed her clock so that its acceleration score has, in her words, “a correlation of r=0.0 with chronological age.” That acceleration score describes whether the model reads you as older or younger than expected for your calendar age. It is not a diagnosis or a direct measurement of how many years remain.

What does “age acceleration” mean, statistically?

Age acceleration sounds like something a sports car does. In these models, it means the difference between a clock result and the result expected for someone your calendar age.

Researchers draw a line through thousands of people plotting predicted age against real age, then measure how far above or below that line you fall. That distance, the residual, is your age acceleration. A positive score means the clock reads you as older than expected for your calendar age; a negative score means younger than expected.

Horvath’s original clock learned this line from 8,000 samples across 51 tissues. GrimAge later linked older-than-expected scores with earlier death in nearly 7,000 people. Both findings describe patterns across groups; neither converts one person’s result into years left to live.

The gap also contains measurement error. In 2022, Albert Higgins-Chen, Morgan Levine and colleagues found that laboratory noise could move six familiar clocks by as much as nine years between runs of the same sample. Their re-engineered versions brought more than 90% of repeats within about 1–1.5 years. If your result says +3, asking which version produced it is not nitpicking. It is the difference between a signal and a lab having a Tuesday. The clock statistics

Why do first-generation and second-generation clocks give different answers?

Because they were trained to predict different things. Same word, “clock,” very different jobs.

  • First-generation clocks were trained to estimate chronological age from biological measurements.
  • Second-generation clocks, including PhenoAge and GrimAge, incorporated disease-risk or mortality information.
  • Pace measures, such as DunedinPACE, estimate a rate of change rather than an age.

The studies and training populations are detailed below.

Levine’s concern was simple: train a clock to guess birthdays and it may ignore biological signals that matter for disease but do not neatly follow the calendar. PhenoAge instead began with nine routine blood values plus age, chosen to distinguish illness and mortality risk among people of the same age. In validation cohorts, each extra DNAm PhenoAge year was associated with a 4.5% rise in mortality risk during follow-up.

So a first-generation clock asks, “How old do you look, molecularly?” A second-generation clock asks, “How much risk do you carry for your age?” Same dashboard word, different warning light. The training populations and results

How does a clock's training goal change the meaning of the age it reports?

How can two 45-year-olds be aging at 0.4 and 2.4 years per year?

The Dunedin Study followed about 1,000 New Zealanders born in 1972–73. Researchers measured 19 indicators across the heart, metabolism, kidneys, liver, immune system, teeth and lungs at ages 26, 32, 38 and 45. At 45, the slowest measured pace was 0.40 biological years per calendar year and the fastest was 2.44. Faster agers also tended to walk and balance less well and showed more cognitive decline. Same birthday; remarkably different mileage.

Daniel Belsky and colleagues then compressed those two decades of change into DunedinPACE, a blood test designed to measure speed rather than position. In roughly 2,500 Framingham participants, faster scores were associated with higher mortality, and repeat runs of the same sample agreed closely. Neither finding proves that lowering the score will extend life.

Belsky and several co-authors are inventors on technology licensed commercially, and NBC reports that Belsky occasionally advises TruDiagnostic, the exclusive licensee. That relationship does not cancel the cohort. It belongs beside the result. The cohorts, statistics and full disclosure

Where has the gap been validated at scale?

Researchers have tested these approaches in the Dunedin Study in New Zealand, US NHANES surveys, the Framingham Heart Study and UK Biobank. These are large research cohorts, not interchangeable samples of every person who might buy a test. The cohort-by-cohort evidence is in the resources below.

In all four, a gap between modelled age and calendar age predicts outcomes in groups. None was designed to hand one person a verdict.

What remains unanswered when an age gap predicts outcomes in groups rather than individuals?

Is “biological age” even one measurable quantity?

This is the counter-case, and it comes from inside the field.

In a 2024 survey, about 100 aging researchers—including Belsky, Horvath and Levine—gave substantially different answers about aging’s definition, causes and possible reversal. The Biomarkers of Aging Consortium has likewise identified the lack of agreed standards as a barrier to clinical validation.

Researchers Idan Shalev and Abner Apsley warn that reducing this complicated process to one number can mislead, especially when a research tool built to sort populations is used to describe an individual. João Pedro de Magalhães made the practical point to MIT Technology Review: five years younger on a clock does not necessarily mean five extra years of life. Younger on the dashboard is not time in the bank.

What’s Interesting

The idea we keep coming back to is Belsky’s reframing: speed versus position. An “age” score estimates accumulated change; a “pace” score estimates the rate of change. One asks how much aging a model detects, the other how quickly its measures are changing.

Elliott, then a Duke doctoral student, pointed out the policy consequence: “Social services, including Medicare and social security, are based on chronological age and kick in later in life, but people who have an accelerated rate of biological aging will have age-related disabilities earlier and often need to retire earlier.” Elliott’s point is that people can develop limitations before reaching the calendar age at which support becomes available. It does not establish that a commercial clock can determine when an individual will need that support.

What This Means in Practice

If you’ve just received a result, the question is not “how old am I really?” but “which clock, which generation, and what’s its repeat error?” A first-generation result is a molecular birthday guess. A PhenoAge, GrimAge or DunedinPACE figure is a group risk statistic, and a DunedinPACE value near 1.0 is the cohort average by construction.

Much of the raw material is already in a standard blood panel. PhenoAge’s phenotypic-age target uses nine routine values plus your age, and the Levine 2018 paper publishes the formula; the Dunedin biomarkers (blood pressure, HbA1c or three-month average blood sugar, lipids, kidney function, CRP, lung function, fitness, dental health) are all things a GP can measure and act on one at a time.

The Dunedin findings show that people born in the same town, in the same couple of years, could have different rates of biological change by midlife. They do not establish a precise personal forecast from a commercial blood test. That would require evidence about the test’s accuracy for individuals, beyond the group findings described here.

The useful next step is a conversation with a primary-care physician or a geriatrician, bringing the individual blood or function results alongside the combined score, and asking: which values fall outside the laboratory’s usual range? What might explain them, and would any finding change care?

Two of the main ways researchers turn that distinction into a number are explained in Phenotypic Age Explained and Pace of Aging Tests Explained.

Bottom Line

Chronological age tells you how long you have lived. Biological-age models estimate different features of aging, and some add information about risk in groups. None turns a younger score into a promise of extra years. For decisions about living longer and better, ask what the test measures, how reliable it is and whether the result changes care supported by clinical evidence.

A NOTE FROM LONGEVITY365

We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.

We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.

Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.

Reader Questions

A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.

  • 01After reading this, what would you want a test result to actually help you decide?
  • 02Which distinction changed how you read the evidence: "What does 'biological age' actually mean, in one blunt sentence" or "Is 'biological age' even one measurable quantity"?
  • 03What would you ask a clinician, lab, or qualified professional before letting a number change a health decision?

Leave a Reply

Your email address will not be published. Required fields are marked *


Extra Insights & Sources

The evidence summaries and linked sources behind this article.

What We Know

  • Chronological age is the strongest single risk factor for most chronic diseases. Established. (NIA; Kennedy 2014)
  • People of the same chronological age differ measurably in their rate of biological change, by a factor of six in the Dunedin cohort. Supported, in one deeply phenotyped cohort with replication of the derived blood test in four others. (Elliott 2021; Belsky 2022)
  • Age acceleration, the residual after regressing a clock’s output on chronological age, predicts mortality and disease incidence in large cohorts: about 4.5% higher mortality per year for PhenoAge, 10% for GrimAge. Supported. (Levine 2018; Lu 2019)
  • Second-generation clocks trained on mortality or phenotypes outperform first-generation clocks trained on chronological age at predicting outcomes. Supported. (Levine 2018)
  • Proteomic clocks reproduce the pattern in 45,441 UK Biobank participants and in Chinese and Finnish cohorts. Supported. (Argentieri 2024)

What We Don’t Know

  • Whether biological age is a single quantity at all. Researchers’ definitions of aging differ substantially. Contested. (Gladyshev 2024)
  • Whether lowering a clock score lowers your risk. No trial has shown that moving the number moves the outcome. Unknown. (Moqri 2023)
  • How much of an individual result is signal. Repeat runs of the same sample differed by up to 9 years on standard clocks. Supported as a limitation. (Higgins-Chen 2022)
  • Which clock, if any, is “right.” There is no reference standard. (Horvath, The Scientist)

Detailed trial results

In the GrimAge clock published in 2019 by Ake Lu, Horvath and colleagues, the acceleration score is defined the same way: GrimAge is regressed on chronological age (the same line-drawing exercise), and the residual is what carries the mortality signal, at a hazard ratio of 1.10 per year of acceleration. A hazard ratio of 1.10 means each extra “year” of acceleration went with roughly 10% higher risk of dying during follow-up, across 6,935 people.

Clock-generation comparison from the original studies discussed in this article:

GenerationTrained to predictExampleTrained onWhat the “gap” means
FirstChronological ageHorvath 20138,000 samples, 82 datasets, 51 tissuesHow far your methylation pattern sits from people your age
SecondMortality or a clinical phenotypePhenoAge (Levine 2018); GrimAge (Lu 2019)NHANES III (n=9,926) for phenotypic age; Framingham (n=1,731) for GrimAgeHow your risk of death or disease compares with people your age
PaceRate of change over timeDunedinPACE (Belsky 2022)Dunedin Study, 19 biomarkers over 20 yearsYears of biological change per calendar year, not an “age” at all

In the Framingham Offspring cohort (n=2,471), a DunedinPACE one standard deviation faster, one statistical notch above the average, carried a mortality hazard ratio of 1.65, and its test-retest reliability, the agreement between two runs of the same sample, reached an intraclass correlation of 0.96, where 1.0 is perfect.

Research populations and model development/validation:

CohortWhat it isWhat was validated there
Dunedin Study (NZ)1,037 people born 1972–73, followed to 45+Pace of Aging, 19 biomarkers over 20 years; DunedinPACE (Elliott 2021; Belsky 2022)
NHANES III (US)9,926 adults in a national health surveyPhenotypic age, the blood-chemistry target PhenoAge was trained on (Levine 2018)
Framingham Heart Study (US)Multi-generation cardiovascular cohort since 1948GrimAge trained in 1,731 people (Lu 2019); DunedinPACE tested in 2,471 (Belsky 2022)
UK Biobank45,441 adults with 2,897 plasma proteins measuredA 204-protein clock predicted chronological age at r=0.94 and was “associated with the incidence of 18 major chronic diseases” and all-cause mortality; replicated in 3,977 people in China and 1,990 in Finland (Argentieri 2024)

Sources

COMING INTO VIEW

Find your people.

The Humanic Blue Directory will help you discover and filter service providers in your area.

This is a preview of what’s to come. The directory isn’t available yet.

Excerpt from the existing editorial library. Local design preview.